Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belinostat + Idarubicin in AML
NCT00878722Phase 2Completed
- Sponsor
- Valerio Therapeutics
- Start
- Aug 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of belinostat in acute myeloid leukemia (AML), sponsored by Valerio Therapeutics. Started Aug 2007; status: completed.
02
Drugs
belinostat
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00878722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878722.